HAC (Russian)
RSCI (Russian)
EBSCO
DOI (USA)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services

PREVENTION OF POSTPARTUM HEMORRHAGE IN SURROGATE MOTHERS

Download full text PDF
Issue: 
9
Year: 
2017

N. Trifonova, Candidate of Medical Sciences; Professor A. Ishchenko, MD; Professor R. Chilova, MD; E. Zhukova, Candidate of Medical Sciences; N. Borisova, Candidate of Medical Sciences; A. Grineva; G. Proklova I.M. Sechenov First Moscow State Medical University (Sechenov University)

The efficiency of carbetocin for the prevention of postpartum hemorrhage was evaluated in surrogate mothers, a high-risk group, during spontaneous labor.

Keywords: 
obstetrics and gynecology
postpartum hemorrhage
prevention
surrogate motherhood



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. World Health Organization. World Health Organization multicountry survey on maternal and newborn health. Geneva: WHO; 2012; World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage / Geneva: WHO, 2014.
  2. Callaghan W., Kuklina E., Berg C. Trends in postpartum hemorrhage: United States, 1994–2006 // Am. J. Obstet. Gynecol. – 2010; 202 (4): 353.
  3. Baev O.R. Profilaktika krovotechenij v posledovom i rannem poslerodovom periode. Aktivnaja ili vyzhidatel'naja taktika? // Akusherstvo i ginekologija. – 2011; 6: 27–30.
  4. Kobzar' N.N., Erbulatova S.T., Dzutseva L.B. i dr. Osobennosti techenija beremennosti i rodov posle EKO po dannym g. 
Almaty za period 2009–2011 gg. // Reproduktivnaja meditsina. – 2011; 3–4: 63–5.
  5. Elenis E., Svanberg A., Lampic C. et al. Adverse obstetric outcomes in pregnancies resulting from oocyte donation: a retrospective cohort case study in Sweden // BMC Pregnancy and Childbirth. – 2015; 15: 247. DOI: 10.1186/s12884-015-0687-9
  6. Trifonova N.S., Zhukova E.V., Grineva A.M. i dr. Klinicheskie osobennosti techenie beremennosti, rodov i perinatal'nye ishody u zhenschin posle EKO s primeneniem donorskih ootsitov // Ros. vestn. akushera-ginekologa. – 2017; 1.
  7. Trifonova N.S., Zhukova E.V., Ischenko A.I. i dr. Surrogatnoe materinstvo. Istoricheskij obzor, osobennosti techenija beremennosti i rodov // Ros. vestn. akushera-ginekologa. – 2015; 15 (2): 49–55. DOI: 10.17116/rosakush201515249-55
  8. Shakurova E.Ju., Ivshin A.A., Jatsuhno L.V. i dr. Mezhdunarodnyj opyt primenenija pabala (karbetotsin) dlja profilaktiki i lechenija poslerodovyh krovotechenij // Ros. vestn. akushera-ginekologa. – 2016; 16 (4): 44–9.
  9. Demetz J., Clouqueur E., D’Haveloose A. et al. Systematic use of carbetocin during cesarean delivery of multiple regnancies: a before-and-after study // Arch. Gynecol. Obstet. – 2013; 287 (5): 875–80.
  10. Feifel D., Shilling P., Belcher A. The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating // Eur. Neuropsychopharmacol. – 2012; 22 (5): 374–8.
  11. Steckler D., Naidoo V., Gerber D. et al. Ex vivo influence of carbetocin on equine myometrial muscles and comparison with oxytocin // Theriogenology. – 2012; 78 (3): 502–9.
  12. Kurtser M.A., Kutakova Ju.Ju., Spiridonova E.I. i dr. Opyt primenenija karbetotsina dlja profilaktiki gipotonicheskih krovotechenij // Akusherstvo i ginekologija. – 2015; 7: 38–42.